Updated 02:01 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,876.40 -0.25% CL 88.33 -0.26% BTC 64,613.34 +0.76%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,876 −0.25% BTC $64,613 +0.76% VIX 19.30 +3.21% latest tape · as of 02:01 UTC
The Screen · Consumer Defensive · Packaged Foods

Central Garden & Pet Company logoCentral Garden & Pet Company

CENT · Nasdaq · USD · Market cap $387M · 6,000 employees

Central Garden & Pet Company produces and distributes various products for the lawn and garden, and pet supplies markets in the United States.

FAIL · Does not pass the screen
47.07 USD

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price47.07 USD at the 13 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.00)
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $41.40 to $65.81, base estimate $52.82 (screen dated 2026-11-13).

Current read
Markup ?
Undervalued · screened 2026-11-13
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.00, read 2026-11-15
  • Ethical does not pass the values gate
Price47.07 USD
Fair value52.82
Ethical score70.0/100
Value readUndervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-11-13Read Markup47.13-0.1% to today Accumulation gives way to Markup after an 18% rise in 5 weeks
2026-10-11Read Accumulation40.10+17.4% to today ✓Markdown gives way to Accumulation first Accumulation read since July
2026-10-02Read Markdown40.10+17.4% to today Markup gives way to Markdown after a 10% slide in 6 weeks
2026-08-24Read Markup44.74+5.2% to today ✓Markdown gives way to Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Central Garden & Pet Company holds its Markup at $47.07. The statistical read favours the sellers, held for 222 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateThe statistical read favours the sellers, held for 222 days
Price at the screen$47.07
Valuation14.85 trailing · 13.12 forward price to earnings
Values screenFAIL · score 70.0
Beta0.54
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 39.73% Below 33% Interest-bearing debt is 39.7% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 33.31% Below 49% Money owed to the company is 33.3% of assets, under the 49% limit. Pass
Revenue purity 0.80% Below 5% Only 0.8% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Central Garden & Pet's business is in a permissible area, but its interest-bearing debt is about 40% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when CENT's ethical verdict changes

Today CENT does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly an 11% discount to our $52.82 fair value.

How a fair value is estimated: discounted cash flow (DCF).

41.40Conservative52.82Base case65.81Growth case 47.07Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 10.9% discount to the base estimate.

The Street's Range
46.00Street low 53.00Street average 60.00Street high 47.07Price

Third-party analyst targets: 2 covering, consensus Buy. The average target sits +13% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $52.82, with a range of $41.40 to $65.81, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Pet treats and lawn feed rarely spark investor excitement

When a dog owner reaches for chews or a gardener stocks up on fertiliser, Central Garden & Pet sits behind the transaction. The business splits between pet supplies and garden products, both steady categories that grow with household spending rather than economic booms. Revenue is rising 9 percent, the forward multiple sits at 14.2 times, and the shares trade 11 percent below our fair value of 48.41 dollars. Yet the opportunity rating remains none, because the 5 percent profit margin and 11 percent return on equity show limited ability to compound capital.

The ethical screen clears without issue, and two analysts carry a buy consensus with a 48 dollar median target. That leaves a narrow gap between price and value, but nothing that suggests durable advantage or accelerating growth. Unknown moat and thin returns on equity keep the story ordinary rather than compelling.

Cyclical garden demand can swing with weather and housing cycles, while pet margins stay under pressure from private-label competition. Low returns signal the risk of value traps where earnings look stable yet fail to lift the share price over time. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E13.1xreasonably valued
Trailing P/E14.9xreasonably valued
EPS, trailing2.70
EPS, forward3.06
Revenue growth-8.2%revenue is shrinking
Profit margin5.4%thin but positive margins
Return on equity10.0%a modest return on shareholder capital
FCF yield13.65%
Debt to equity0.81moderate, manageable leverage
Current ratio3.79comfortably covers its short-term bills
Beta0.54steadier than the market
Short interest, float0.08%
52-week range28.77 - 46.97
Market cap$387M
Employees6,000

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

CENT trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-13 Markup · changed $47.13 -1.7% Entry 11

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (2 analysts) rates it none, with a mean price target of $48.

2026-11-06 Accumulation $47.94 +7.9% Entry 10

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (2 analysts) rates it none, with a mean price target of $48.

2026-10-30 Accumulation $44.43 +5.9% Entry 9

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (2 analysts) rates it none, with a mean price target of $48.

2026-10-23 Accumulation $41.95 +4.6% Entry 8

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (2 analysts) rates it none, with a mean price target of $48.

2026-10-11 Accumulation · changed $40.10 +0.0% Entry 7

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (2 analysts) rates it none, with a mean price target of $48.

2026-10-02 Markdown · changed $40.10 -10.4% Entry 6

The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 10.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (2 analysts) rates it none, with a mean price target of $48.

2026-08-24 Markup · changed $44.74 +2.6% Entry 5

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (2 analysts) rates it none, with a mean price target of $48.

2026-07-24 Markdown · changed $43.61 +1.8% Entry 4

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (2 analysts) rates it none, with a mean price target of $48.

2026-07-18 Accumulation $42.85 +0.0% Entry 3

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (2 analysts) rates it none, with a mean price target of $48.

2026-07-03 Accumulation $42.85 +0.0% Entry 2

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on CENT

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in CENT's Space

Screened names in the same industry · explore each on its own page.

The Political Ledger · Congressional Disclosures
Disclosures naming CENT
DatePoliticianPartyTypeAmount
2026-10-21 Ro Khanna Democrat sell 1K–15K
2026-10-21 Ro Khanna Democrat sell 1K–15K
2026-10-21 Ro Khanna Democrat sell 1K–15K
2026-10-13 Ro Khanna Democrat buy 1K–15K
2026-10-07 Ro Khanna Democrat buy 15K–50K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $37.76 +11.3% · $1,113 +11.3%
2 months $37.38 +12.4% · $1,124 +12.4%
3 months $36.49 +15.2% · $1,152 +15.2%
6 months $33.76 +24.5% · $1,245 +24.5%
1 year $36.33 +15.7% · $1,157 +15.7%
2 years $40.69 +3.3% · $1,033 +3.3%
3 years $29.77 +41.2% · $1,412 +41.2%
5 years $43.78 -4.0% · $960 -4.0%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever CENT does next, these words stay.

Central Garden & Pet Company · CENT · Markup · $47.07
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.